CRISPR Therapeutics
CRSP
#3304
Rank
C$4.68 B
Marketcap
$54.23
Share price
1.48%
Change (1 day)
-28.89%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.18

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.35. In 2022 the company made an earnings per share (EPS) of -$11.61 a decrease over its 2021 EPS that were of $6.92.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.18-38.13%
2022-$11.61-267.74%
2021$6.92-194.33%
2020-$7.34-576.58%
2019$1.54-132.36%
2018-$4.76100.58%
2017-$2.37159.42%
2016-$0.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.02-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA